Deepecho

Democratizing quality ultrasound

Employees
11–50
Business Model
B2B
Last Round
Pre-SeedFeb 2022
Rounds
1

About

DeepEcho is a healthtech company building AI-powered fetal ultrasound analysis software to improve prenatal care and reduce infant and maternal mortality. Founded by AI scientists and physicians, DeepEcho uses deep learning algorithms to automate fetal measurements, assist with computer-aided diagnosis, and enable teleguidance for remote diagnosis — enabling screenings that are 3 to 5 times faster with greater than 95% accuracy. The platform is hardware-agnostic and mobile-compatible, designed for deployment in low-resource settings. DeepEcho received FDA 510(k) clearance in 2025 and has been backed by the Bill & Melinda Gates Foundation I3 Program and the European Bank for Reconstruction and Development.

Summary

Deepecho is a Healthcare company based in San Francisco, United States. Its most recent funding was a Pre-Seed round in Feb 2022. Investors include UM6P Ventures and Plug and Play.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Pre-seedPre-SeedFeb 2022

Investors

Similar Companies